14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.583 1 day ( 0 % )
Last Price $15.86 2.79 %
High/ Low $15.70 - $15.90 12.48%
Chg 7 Days 10.22 % $14.39 $15.86
Chg 30 Days -0.0630 % $15.87 $15.86
Chg 12 mos 20.52 % $13.16 $15.86
Trend - 3 mos -8.15 % Width: 21.57 %
Trend - 12 mos 21.92 % Width: 67.43 %
Pred. range - 3 mos $12.68 - $15.42 -20.04 % - -2.80 %
Pred. range - 12 mos $13.41 - $22.46 -15.42 % - 41.61 %
Short MA avg 3 mos Buy Apr 25, 2024 - 7 days
Long MA avg 3 mos Buy May 02, 2024 - 2 days
Short/Long MA avg 3 mos Sell Mar 21, 2024 - 31 days
Short MA avg 12 mos Buy Apr 30, 2024 - 4 days
Long MA avg 12 mos Buy Apr 26, 2024 - 6 days
Short/Long MA avg 12 mos Buy Dec 14, 2023 - 97 days
Pivot Short Sell Apr 25, 2024 - 7 days
Bollinger Buy Apr 22, 2024 - 10 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Loncar Cancer Immunotherapy ETF

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The fund attempts to invest all, or substantiall... CNCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT